Ticagrelor is an antiplatelet therapy that is an alternative to aspirin for preventing recurrent stroke. Does ticagrelor produce better outcomes than aspirin? New research findings are summarized in a new NEJM Quick Take video. Learn more at
Hide player controls
Hide resume playing